Liam Condon Acquires 10 Shares of Johnson Matthey (LON:JMAT) Stock

Johnson Matthey PLC (LON:JMATGet Free Report) insider Liam Condon bought 10 shares of the firm’s stock in a transaction on Tuesday, January 13th. The shares were acquired at an average price of GBX 2,321 per share, for a total transaction of £232.10.

Liam Condon also recently made the following trade(s):

  • On Wednesday, December 10th, Liam Condon purchased 14 shares of Johnson Matthey stock. The stock was acquired at an average price of GBX 2,013 per share, with a total value of £281.82.
  • On Wednesday, November 12th, Liam Condon purchased 10 shares of Johnson Matthey stock. The stock was bought at an average price of GBX 2,165 per share, with a total value of £216.50.

Johnson Matthey Price Performance

LON:JMAT traded up GBX 6.30 during trading hours on Wednesday, reaching GBX 2,356.30. 134,417 shares of the company were exchanged, compared to its average volume of 1,432,008. The company has a market capitalization of £3.95 billion, a P/E ratio of -35.76, a P/E/G ratio of 49,242.50 and a beta of 0.95. The company has a debt-to-equity ratio of 62.73, a current ratio of 1.45 and a quick ratio of 0.76. The business has a 50 day moving average of GBX 2,112.76 and a 200 day moving average of GBX 1,995.33. Johnson Matthey PLC has a 1-year low of GBX 1,131 and a 1-year high of GBX 2,382.

Johnson Matthey (LON:JMATGet Free Report) last released its earnings results on Thursday, November 20th. The company reported GBX 51.20 earnings per share for the quarter. Johnson Matthey had a return on equity of 4.49% and a net margin of 0.84%. Research analysts forecast that Johnson Matthey PLC will post 173.4112903 EPS for the current year.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. Berenberg Bank reduced their price target on shares of Johnson Matthey from GBX 2,100 to GBX 2,050 and set a “hold” rating on the stock in a research report on Tuesday, November 25th. Panmure Gordon restated a “buy” rating and set a GBX 2,370 target price on shares of Johnson Matthey in a research note on Monday, November 24th. Citigroup lifted their price target on Johnson Matthey from GBX 1,800 to GBX 2,100 and gave the company a “neutral” rating in a research note on Tuesday, October 21st. Jefferies Financial Group boosted their price target on Johnson Matthey from GBX 2,200 to GBX 2,420 and gave the stock a “buy” rating in a report on Tuesday, October 14th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a research note on Thursday, October 9th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of GBX 2,248.

Read Our Latest Research Report on JMAT

Johnson Matthey Company Profile

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.

Featured Articles

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.